# Mustafa Industries

> Houston, Texas medical-device and AI company building wearable, AI-driven devices that detect health risks before symptoms appear. Four products: Neura, Spira, Pharyna, LabLens AI. Plexus = the unifying FHIR-native data plane.

## About

Mustafa Industries is a biomedical-AI venture headquartered in Houston, Texas, founded by Arsal Mustafa at the University of Houston. We design and prototype a family of compact, AI-powered biosignal devices and the FHIR-native data plane that connects them. Our thesis: most disease is detected too late; continuous, on-device AI monitoring catches the signal before the symptom, and one shared AI platform across an entire device family compounds with each new product.

## Founder

- Founder & CEO: Arsal Mustafa — University of Houston, Houston, TX
- Contact: arsal.ala.mustafa@gmail.com

## Fundraising

- Raising $250,000 at a $1.5M pre-money valuation
- Non-dilutive: NSF SBIR Phase I application in progress
- Patent pending
- Use of funds (Neura deck breakdown): Hardware/manufacturing 38%, AI & cloud 22%, Regulatory/clinical 18%, Marketing 12%, Legal/IP/ops 6%, Contingency 4%

## Product Portfolio

### Neura — AI EEG Neural Patch (active prototype)
Behind-the-ear (mastoid) patch under 18 g that predicts migraines and stress events 30 minutes to 6 hours before onset by fusing multimodal biosignals into a real-time 0–100 risk score updated every 30 s. 2-channel EEG (TP9/TP10, 256 Hz, ADS1299 AFE), PPG (MAX30102), EDA (hydrogel, 4–64 Hz), skin temperature (TMP117), IMU. Two-stage ML: Stage 1 XGBoost/LightGBM + Stage 2 LSTM with 7-day per-user calibration. Trained on PhysioNet Cognitive States, ScientISST MOVE, Kaggle Migraine + QEEG biomarker thresholds. Battery 8+ hr, IPX4. Target retail $350. Status: full hardware design complete; MVP simulation code, not yet validated on Neura hardware. TAM $22B / SAM $6.2B / SOM $310M.

### Spira — AI Spirometer (active prototype)
Handheld 150 mm spirometer measuring FEV1, FVC, FEV1/FVC ratio, and Peak Expiratory Flow against ATS/ERS criteria. Honeywell HSCDANN005PG2A3 differential pressure sensor; STM32/ESP32-S3 + BLE; 30×12 mm OLED; TPU bayonet twist-lock mouthpiece; 18650 Li-Ion; USB-C. Trained on NHANES 2007–2012 (16,596 subjects), Kaggle Lung Disease (37k records), PhysioNet BIDMC. Per-user baseline by age/sex/BMI/height; longitudinal trend analysis; HL7 FHIR export planned. Hardware BOM ≈ $146/unit (10-unit prototype batch); target retail $450; 45% target GM. TAM $28B / SAM $6.8B / SOM $340M. FDA 510(k), De Novo or predicate route.

### Pharyna — AI Dysphagia Patch (Phase 1 clinical validation)
Flexible 60 × 40 mm anterior-neck patch that detects silent aspiration in real time using sEMG (submental/infrahyoid muscle activation) + contact accelerometer / acoustic mic (vibroacoustic swallow signature) + skin temperature. ESP32-S3 + BLE; hydrogel electrodes; LiPo 8+ hr; IPX4. On-device 4-class model (Normal swallow / Silent aspiration / Overt aspiration / Non-swallow) trained on USC Swallowing + Purdue Tele-EaT + VFSS-annotated data. Published evidence base: Park 2020 (91.3%/88.7% sens/spec), Dudik 2015 (89.4%), Lee 2021 (sEMG+acoustic fusion +8–14% over single-sensor), Khalifa 2023 (92% on VFSS). Market: stroke ~2.4M, ALS ~30K, Parkinson's ~500K, nursing-home ~400–600K, post-extubation ~300K/yr, head & neck cancer ~65K/yr. Hardware $200–350 + subscription $50–100/mo; reimbursable via RPM CPT 99453/99454/99457. FDA Class II 510(k), 12–18 mo timeline.

### LabLens AI — Educational Lab-Result Web App (live)
Free public web app at lablens.ai. Paste any lab report — blood test, CBC, CMP, lipid panel, thyroid panel, urinalysis — and receive a marker-by-marker plain-language explanation in seconds. Structured output: status (high/low/normal/borderline/unknown), what the value may be associated with, what clinicians commonly evaluate next, and questions to ask a doctor. Built on Next.js 14 + Anthropic Claude API with forced tool use for guaranteed structured JSON. Rate-limited, cost-capped, zero server-side storage of lab text. Strictly educational; intentionally outside FDA scope by design.

### Plexus — FHIR-native Biosignal Data Plane (in development)
Cloud backend that unifies all four products. Fastify + Postgres + JSONB. FHIR R4 REST API (Patient, Device, Observation, Patient/$everything bulk export, capability statement at /fhir/metadata). Real-time WebSocket biosignal ingest. Unified per-patient physiological context vector at /context/:patientId. Event-sourced raw_stream table. HIPAA-grade audit log. Helmet security headers, per-IP rate limiting, CORS allow-list, JWT with production secrets guard, pino-redacted logs.

## Technology

- On-device AI on ESP32-S3 microcontrollers across all three hardware devices
- BLE 5 to a unified mobile companion app
- HTTPS / WSS to Plexus (FHIR R4) for cloud ingest
- Models pre-trained on open biomedical datasets (PhysioNet, NHANES, MIMIC, USC Swallowing, Purdue Tele-EaT, ScientISST, Kaggle) and personalized per-patient on-device
- LabLens AI: separate stack — Next.js 14 + Vercel + Claude API

## Regulatory

- Neura: FDA 510(k) vs. general-wellness classification under evaluation; HL7 FHIR planned
- Spira: FDA 510(k), De Novo or predicate route (advisory in progress); ATS/ERS standards
- Pharyna: FDA Class II 510(k), 12–18 mo timeline; ISO 13485 + ISO 10993 required
- LabLens AI: not a medical device; safety enforced via system prompt + on-page disclaimer
- Recurring standards: ISO 13485 (QMS), ISO 10993 (biocompatibility), HL7 FHIR (EMR export)

## Markdown Mirrors (Clean AI-Readable Versions)

Every page on this site has a plain markdown mirror. Add `/index.md` to the homepage or `.md` to other URLs for the clean content without navigation, scripts, or layout chrome.

- https://mustafaindustries.com/index.md
- https://mustafaindustries.com/privacy.md

## Frequently Asked Questions

**What does Mustafa Industries do?**
Mustafa Industries builds wearable, AI-driven medical devices that detect health risks before symptoms appear. Four products: Neura (AI EEG patch), Spira (AI spirometer), Pharyna (AI dysphagia patch), and LabLens AI (educational lab-result web app). Plexus is the FHIR-native data plane connecting them all.

**Where is Mustafa Industries based?**
Houston, Texas. Founded at the University of Houston.

**What stage is the company at?**
Spira and Neura are active prototypes. Pharyna is in Phase 1 clinical validation. LabLens AI is publicly live at lablens.ai. Plexus, the FHIR-native backend, is in development. Raising $250K at a $1.5M pre-money valuation. NSF SBIR Phase I in progress. Patent pending.

**Who is the founder of Mustafa Industries?**
Arsal Mustafa, a founder out of the University of Houston in Houston, Texas. Email arsal.ala.mustafa@gmail.com.

**Are the Mustafa Industries devices FDA-cleared?**
Not yet. The hardware devices are in prototype or Phase 1 validation stages. No diagnostic claims are made and the devices are not sold to the public. LabLens AI is strictly educational.

**What is LabLens AI and how is it different from a doctor?**
LabLens AI is a free educational web tool that translates lab reports into plain English so you can have a more informed conversation with your physician. It does not diagnose, recommend medication, or replace professional medical advice. It works on common panels including CBC, CMP, lipids, thyroid, and urinalysis. Available at lablens.ai.

**What makes Mustafa Industries different from other med-tech startups?**
One unified AI platform across an entire family of medical devices, not a single point product. The same on-device inference pipeline that powers Spira (lung) is reused for Neura (neural) and Pharyna (swallowing). Plexus unifies every signal as standard FHIR resources. Each new device compounds the platform's value rather than starting from zero.

**Is Mustafa Industries raising capital?**
Yes — $250K at a $1.5M pre-money valuation. The round funds prototype manufacturing, FDA pre-submission advisory, clinical validation, and NSF SBIR Phase I preparation. Email arsal.ala.mustafa@gmail.com for the deck.

**How can I follow your progress or get in touch?**
Email arsal.ala.mustafa@gmail.com. The marketing site at mustafaindustries.com has the current device roadmap and investor materials.

## What Makes Us Different

One unified AI platform across an entire family of medical devices. Each new device — Neura, Spira, Pharyna, and others to come — runs the same on-device inference pipeline and reports through the same Plexus FHIR data plane. This compounds the platform's value device-by-device and gives clinicians a single, FHIR-native view of a patient's biosignals.

## Trademarks

Mustafa Industries™, Neura™, Spira™, Pharyna™, LabLens™, LabLens AI™, and Plexus™ are trademarks of Mustafa Industries. Patent pending.